Contact
Please use this form to send email to PR contact of this press release:
SHAREHOLDER UPDATE: Y-mAbs Therapeutics, Bioventus Inc, Fate Therapeutics, Inc, and Invivyd Inc: Johnson Fistel Encourages Shareholders to Seek Counsel for Class Action Lawsuits
TO: